Article
Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020.
Journal of Clinical Oncology
(2017)
Disciplines
Publication Date
January 30, 2017
Citation Information
Howard Kaufman, Jose Lutzky, Joseph Clark, Kim Allyson Margolin, et al.. "Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020." Journal of Clinical Oncology (2017) Available at: http://works.bepress.com/walter-urba/102/